Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 112 | 2024 | 2044 | 15.230 |
Why?
|
Papillomavirus Infections | 95 | 2024 | 1640 | 13.930 |
Why?
|
Papillomavirus Vaccines | 63 | 2024 | 497 | 12.760 |
Why?
|
Early Detection of Cancer | 61 | 2024 | 3238 | 6.350 |
Why?
|
Uterine Cervical Dysplasia | 23 | 2024 | 392 | 5.200 |
Why?
|
Cost-Benefit Analysis | 80 | 2024 | 5544 | 4.680 |
Why?
|
Papillomaviridae | 27 | 2024 | 1140 | 4.530 |
Why?
|
Mass Screening | 54 | 2024 | 5455 | 3.640 |
Why?
|
Vaccination | 41 | 2024 | 3436 | 3.420 |
Why?
|
Colposcopy | 23 | 2024 | 151 | 2.970 |
Why?
|
Models, Theoretical | 25 | 2024 | 3580 | 2.600 |
Why?
|
Human papillomavirus 16 | 21 | 2024 | 268 | 2.600 |
Why?
|
Human papillomavirus 18 | 18 | 2023 | 125 | 2.440 |
Why?
|
Vaginal Smears | 18 | 2024 | 505 | 2.400 |
Why?
|
Alphapapillomavirus | 10 | 2022 | 219 | 2.180 |
Why?
|
Health Policy | 13 | 2019 | 2700 | 1.900 |
Why?
|
Quality-Adjusted Life Years | 25 | 2023 | 1741 | 1.560 |
Why?
|
Health Care Costs | 13 | 2022 | 3270 | 1.280 |
Why?
|
Mass Vaccination | 3 | 2019 | 111 | 1.220 |
Why?
|
Computer Simulation | 14 | 2021 | 6289 | 1.170 |
Why?
|
Models, Economic | 9 | 2022 | 721 | 1.080 |
Why?
|
Personality Disorders | 4 | 2013 | 729 | 1.070 |
Why?
|
Anus Neoplasms | 5 | 2018 | 336 | 0.900 |
Why?
|
Decision Support Techniques | 6 | 2019 | 2008 | 0.890 |
Why?
|
Norway | 10 | 2024 | 501 | 0.880 |
Why?
|
Immunization Schedule | 3 | 2024 | 228 | 0.820 |
Why?
|
Monte Carlo Method | 11 | 2021 | 1262 | 0.820 |
Why?
|
Psychotherapy | 5 | 2015 | 1654 | 0.800 |
Why?
|
Female | 141 | 2024 | 397464 | 0.780 |
Why?
|
DNA, Viral | 10 | 2017 | 2205 | 0.770 |
Why?
|
Health Resources | 4 | 2017 | 951 | 0.720 |
Why?
|
Practice Guidelines as Topic | 11 | 2021 | 7460 | 0.690 |
Why?
|
Tumor Virus Infections | 2 | 2018 | 437 | 0.670 |
Why?
|
Developed Countries | 4 | 2024 | 452 | 0.660 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 530 | 0.640 |
Why?
|
Adult | 78 | 2024 | 223818 | 0.630 |
Why?
|
Uganda | 7 | 2019 | 1354 | 0.600 |
Why?
|
Humans | 155 | 2024 | 768887 | 0.590 |
Why?
|
Healthcare Disparities | 4 | 2023 | 3421 | 0.580 |
Why?
|
Incidence | 22 | 2024 | 21545 | 0.580 |
Why?
|
Developing Countries | 10 | 2020 | 2906 | 0.570 |
Why?
|
Models, Statistical | 10 | 2021 | 5107 | 0.550 |
Why?
|
Self-Examination | 1 | 2016 | 71 | 0.540 |
Why?
|
Young Adult | 36 | 2024 | 60110 | 0.530 |
Why?
|
Genital Neoplasms, Female | 2 | 2012 | 538 | 0.500 |
Why?
|
El Salvador | 4 | 2019 | 34 | 0.490 |
Why?
|
Middle Aged | 55 | 2024 | 223740 | 0.470 |
Why?
|
Immunization Programs | 2 | 2015 | 267 | 0.460 |
Why?
|
Heart Valve Diseases | 1 | 2021 | 1030 | 0.430 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 132 | 0.410 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 428 | 0.410 |
Why?
|
Adolescent | 39 | 2024 | 89247 | 0.410 |
Why?
|
Genital Neoplasms, Male | 1 | 2012 | 68 | 0.400 |
Why?
|
United States | 34 | 2024 | 73180 | 0.390 |
Why?
|
Health Status Disparities | 1 | 2023 | 1886 | 0.390 |
Why?
|
Age Factors | 12 | 2020 | 18454 | 0.380 |
Why?
|
Precancerous Conditions | 2 | 2017 | 985 | 0.370 |
Why?
|
Choice Behavior | 1 | 2017 | 848 | 0.370 |
Why?
|
Meningococcal Vaccines | 1 | 2011 | 96 | 0.370 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2011 | 39 | 0.370 |
Why?
|
Cytological Techniques | 3 | 2021 | 218 | 0.360 |
Why?
|
Population Surveillance | 3 | 2019 | 2597 | 0.360 |
Why?
|
Models, Biological | 7 | 2020 | 9499 | 0.360 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1568 | 0.360 |
Why?
|
Vulvar Neoplasms | 2 | 2013 | 266 | 0.350 |
Why?
|
Patient Compliance | 2 | 2021 | 2701 | 0.350 |
Why?
|
Selection Bias | 1 | 2011 | 360 | 0.340 |
Why?
|
Child | 29 | 2024 | 80969 | 0.330 |
Why?
|
Oropharyngeal Neoplasms | 4 | 2023 | 493 | 0.330 |
Why?
|
Cervix Uteri | 4 | 2022 | 576 | 0.330 |
Why?
|
Bayes Theorem | 1 | 2017 | 2357 | 0.320 |
Why?
|
Specimen Handling | 4 | 2021 | 708 | 0.310 |
Why?
|
American Cancer Society | 3 | 2024 | 69 | 0.310 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 714 | 0.310 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5375 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2543 | 0.280 |
Why?
|
HIV Infections | 3 | 2018 | 17589 | 0.270 |
Why?
|
Condylomata Acuminata | 3 | 2012 | 79 | 0.270 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1119 | 0.270 |
Why?
|
Cost of Illness | 3 | 2015 | 1959 | 0.270 |
Why?
|
Calibration | 2 | 2018 | 823 | 0.240 |
Why?
|
India | 3 | 2021 | 2325 | 0.240 |
Why?
|
Markov Chains | 3 | 2019 | 979 | 0.240 |
Why?
|
Uncertainty | 4 | 2024 | 769 | 0.240 |
Why?
|
Public Health | 2 | 2017 | 2680 | 0.240 |
Why?
|
Time | 2 | 2020 | 552 | 0.240 |
Why?
|
Aged | 27 | 2021 | 171790 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2181 | 0.240 |
Why?
|
Decision Making | 3 | 2017 | 3952 | 0.230 |
Why?
|
Netherlands | 4 | 2011 | 2277 | 0.230 |
Why?
|
Mississippi | 2 | 2021 | 94 | 0.230 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2017 | 4064 | 0.230 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2016 | 620 | 0.220 |
Why?
|
Mental Health Services | 2 | 2015 | 1732 | 0.210 |
Why?
|
Federal Government | 1 | 2024 | 266 | 0.210 |
Why?
|
Neoplasms | 5 | 2023 | 22390 | 0.200 |
Why?
|
Office Visits | 1 | 2006 | 596 | 0.200 |
Why?
|
Colorectal Neoplasms | 7 | 2023 | 6982 | 0.200 |
Why?
|
Financing, Government | 2 | 2016 | 473 | 0.200 |
Why?
|
Risk Management | 3 | 2024 | 558 | 0.200 |
Why?
|
Sensitivity and Specificity | 7 | 2020 | 14751 | 0.190 |
Why?
|
New Mexico | 3 | 2018 | 81 | 0.190 |
Why?
|
Patient Acceptance of Health Care | 1 | 2015 | 3233 | 0.190 |
Why?
|
Advisory Committees | 2 | 2018 | 797 | 0.180 |
Why?
|
Suicide | 1 | 2012 | 1606 | 0.180 |
Why?
|
Kenya | 2 | 2014 | 758 | 0.180 |
Why?
|
Life Expectancy | 2 | 2018 | 1249 | 0.180 |
Why?
|
Viral Vaccines | 1 | 2006 | 596 | 0.180 |
Why?
|
Occult Blood | 3 | 2017 | 199 | 0.170 |
Why?
|
Male | 32 | 2023 | 365249 | 0.160 |
Why?
|
Psychotherapy, Brief | 1 | 2020 | 118 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2004 | 790 | 0.150 |
Why?
|
Geography | 1 | 2020 | 654 | 0.150 |
Why?
|
Carcinoembryonic Antigen | 1 | 2019 | 338 | 0.150 |
Why?
|
Politics | 1 | 2024 | 822 | 0.150 |
Why?
|
Nicaragua | 1 | 2017 | 29 | 0.150 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2015 | 300 | 0.140 |
Why?
|
Endometrial Neoplasms | 1 | 2007 | 1386 | 0.140 |
Why?
|
Africa, Northern | 2 | 2013 | 86 | 0.140 |
Why?
|
Time Factors | 6 | 2018 | 40266 | 0.140 |
Why?
|
Breast Neoplasms | 8 | 2023 | 21187 | 0.140 |
Why?
|
Algorithms | 1 | 2017 | 14199 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 10397 | 0.130 |
Why?
|
Immunity, Herd | 1 | 2016 | 48 | 0.130 |
Why?
|
Middle East | 2 | 2013 | 233 | 0.130 |
Why?
|
Lebanon | 1 | 2016 | 245 | 0.130 |
Why?
|
Survival Rate | 3 | 2019 | 12873 | 0.130 |
Why?
|
Age of Onset | 2 | 2020 | 3346 | 0.130 |
Why?
|
Cryosurgery | 2 | 2018 | 477 | 0.130 |
Why?
|
Triage | 3 | 2023 | 997 | 0.120 |
Why?
|
Penile Neoplasms | 2 | 2013 | 158 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2023 | 1042 | 0.120 |
Why?
|
Forecasting | 2 | 2020 | 2946 | 0.120 |
Why?
|
Income | 3 | 2020 | 1878 | 0.120 |
Why?
|
Hysterectomy | 1 | 2020 | 866 | 0.120 |
Why?
|
Brazil | 3 | 2007 | 1249 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 468 | 0.120 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 7860 | 0.120 |
Why?
|
Research Support as Topic | 2 | 2015 | 696 | 0.120 |
Why?
|
Hepatitis C, Chronic | 1 | 2022 | 1033 | 0.120 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4819 | 0.120 |
Why?
|
Asia, Central | 1 | 2013 | 13 | 0.110 |
Why?
|
Africa South of the Sahara | 2 | 2013 | 752 | 0.110 |
Why?
|
Europe, Eastern | 1 | 2013 | 72 | 0.110 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.110 |
Why?
|
Treatment Outcome | 8 | 2022 | 65485 | 0.110 |
Why?
|
Likelihood Functions | 1 | 2017 | 993 | 0.110 |
Why?
|
Guideline Adherence | 2 | 2015 | 2240 | 0.110 |
Why?
|
Mental Disorders | 1 | 2014 | 6879 | 0.110 |
Why?
|
Policy Making | 1 | 2017 | 546 | 0.110 |
Why?
|
Vaginal Neoplasms | 1 | 2013 | 105 | 0.110 |
Why?
|
Social Class | 2 | 2023 | 2009 | 0.100 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13593 | 0.100 |
Why?
|
Cross Protection | 1 | 2012 | 25 | 0.100 |
Why?
|
False Negative Reactions | 1 | 2014 | 575 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1476 | 0.100 |
Why?
|
South Africa | 1 | 2018 | 1872 | 0.100 |
Why?
|
Pregnancy | 6 | 2024 | 30175 | 0.100 |
Why?
|
Mitral Valve | 1 | 2021 | 1475 | 0.100 |
Why?
|
Virology | 1 | 2012 | 76 | 0.100 |
Why?
|
Hepatitis C | 1 | 2022 | 1595 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2598 | 0.100 |
Why?
|
Prevalence | 5 | 2021 | 15875 | 0.100 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 417 | 0.100 |
Why?
|
rab GTP-Binding Proteins | 1 | 2013 | 247 | 0.100 |
Why?
|
Risk Factors | 7 | 2018 | 74971 | 0.100 |
Why?
|
Age Distribution | 3 | 2017 | 2875 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1398 | 0.090 |
Why?
|
Military Personnel | 1 | 2020 | 1264 | 0.090 |
Why?
|
Decision Trees | 2 | 2009 | 509 | 0.090 |
Why?
|
Quality Improvement | 2 | 2016 | 3856 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2017 | 2437 | 0.080 |
Why?
|
Stress, Psychological | 2 | 2015 | 4542 | 0.080 |
Why?
|
Aftercare | 1 | 2016 | 921 | 0.080 |
Why?
|
Women's Health | 2 | 2011 | 2081 | 0.080 |
Why?
|
Program Development | 1 | 2016 | 1300 | 0.080 |
Why?
|
Program Evaluation | 2 | 2016 | 2507 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2017 | 3626 | 0.080 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 417 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11262 | 0.080 |
Why?
|
Ethiopia | 2 | 2021 | 483 | 0.080 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 390 | 0.080 |
Why?
|
Spain | 1 | 2010 | 485 | 0.080 |
Why?
|
Biopsy | 2 | 2018 | 6805 | 0.080 |
Why?
|
Pacific Islands | 1 | 2008 | 52 | 0.080 |
Why?
|
China | 1 | 2015 | 2395 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4926 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15471 | 0.080 |
Why?
|
Genotype | 2 | 2020 | 13048 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2018 | 2200 | 0.080 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1409 | 0.080 |
Why?
|
Pharyngeal Neoplasms | 1 | 2008 | 113 | 0.080 |
Why?
|
Hong Kong | 2 | 2007 | 170 | 0.070 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2010 | 395 | 0.070 |
Why?
|
Homosexuality, Male | 2 | 2019 | 1344 | 0.070 |
Why?
|
Vietnam | 1 | 2008 | 415 | 0.070 |
Why?
|
Endoplasmic Reticulum | 1 | 2013 | 1133 | 0.070 |
Why?
|
Costa Rica | 2 | 2021 | 186 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5520 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 13677 | 0.070 |
Why?
|
Asia | 1 | 2008 | 629 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3279 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2537 | 0.070 |
Why?
|
DNA Probes, HPV | 1 | 2006 | 21 | 0.070 |
Why?
|
Quality of Life | 3 | 2021 | 13510 | 0.070 |
Why?
|
Immunization | 1 | 2010 | 1219 | 0.070 |
Why?
|
Consensus | 3 | 2024 | 3214 | 0.070 |
Why?
|
Mammography | 3 | 2017 | 2434 | 0.060 |
Why?
|
Registries | 3 | 2018 | 8384 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20244 | 0.060 |
Why?
|
Autophagy | 1 | 2013 | 1351 | 0.060 |
Why?
|
Disease Transmission, Infectious | 1 | 2011 | 560 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2359 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9621 | 0.060 |
Why?
|
Sierra Leone | 2 | 2015 | 171 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 59738 | 0.060 |
Why?
|
National Health Programs | 1 | 2008 | 442 | 0.060 |
Why?
|
Finland | 1 | 2006 | 609 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2015 | 6031 | 0.060 |
Why?
|
Actuarial Analysis | 1 | 2004 | 372 | 0.060 |
Why?
|
Infant | 4 | 2023 | 36541 | 0.060 |
Why?
|
France | 1 | 2005 | 497 | 0.060 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2013 | 1839 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1989 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 500 | 0.060 |
Why?
|
Reproductive Health Services | 1 | 2024 | 90 | 0.050 |
Why?
|
Students | 2 | 2018 | 1744 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2010 | 2730 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2008 | 597 | 0.050 |
Why?
|
Italy | 1 | 2005 | 855 | 0.050 |
Why?
|
Caregivers | 1 | 2015 | 2308 | 0.050 |
Why?
|
Pilot Projects | 1 | 2016 | 8742 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4053 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4576 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3925 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2021 | 70 | 0.050 |
Why?
|
Pakistan | 1 | 2021 | 298 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39394 | 0.040 |
Why?
|
Hospitalization | 2 | 2010 | 10845 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8559 | 0.040 |
Why?
|
Risk Assessment | 4 | 2020 | 24330 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2010 | 2783 | 0.040 |
Why?
|
Cohort Studies | 5 | 2018 | 41800 | 0.040 |
Why?
|
Colonoscopy | 1 | 2007 | 1410 | 0.040 |
Why?
|
Nigeria | 1 | 2021 | 779 | 0.040 |
Why?
|
Policy | 1 | 2022 | 514 | 0.040 |
Why?
|
Sweden | 1 | 2020 | 1382 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4265 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14795 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2002 | 971 | 0.030 |
Why?
|
Length of Stay | 1 | 2010 | 6525 | 0.030 |
Why?
|
Standard of Care | 1 | 2020 | 570 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10641 | 0.030 |
Why?
|
Hepacivirus | 1 | 2022 | 1344 | 0.030 |
Why?
|
Self Care | 1 | 2020 | 801 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3463 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 81892 | 0.030 |
Why?
|
Cryotherapy | 1 | 2016 | 164 | 0.030 |
Why?
|
SEER Program | 1 | 2020 | 1473 | 0.030 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2024 | 1189 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 266 | 0.030 |
Why?
|
Societies, Medical | 2 | 2020 | 3967 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2020 | 26394 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1327 | 0.030 |
Why?
|
Conduct Disorder | 1 | 2015 | 245 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11229 | 0.030 |
Why?
|
Tissue Donors | 1 | 2022 | 2382 | 0.030 |
Why?
|
Public Policy | 1 | 2016 | 552 | 0.020 |
Why?
|
Physical Examination | 1 | 2018 | 1262 | 0.020 |
Why?
|
Africa, Eastern | 1 | 2011 | 76 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2013 | 407 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42684 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1511 | 0.020 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2013 | 497 | 0.020 |
Why?
|
Morbidity | 1 | 2016 | 1757 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3069 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2018 | 1190 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5323 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2915 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2012 | 453 | 0.020 |
Why?
|
Primary Prevention | 1 | 2016 | 1187 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4055 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2015 | 2742 | 0.020 |
Why?
|
Lysosomes | 1 | 2013 | 940 | 0.020 |
Why?
|
Protein Transport | 1 | 2013 | 1956 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1141 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20776 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2012 | 1627 | 0.020 |
Why?
|
Survival Analysis | 2 | 2011 | 10115 | 0.020 |
Why?
|
Direct Service Costs | 1 | 2006 | 61 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5890 | 0.020 |
Why?
|
Lung | 1 | 2023 | 10097 | 0.010 |
Why?
|
Massachusetts | 1 | 2018 | 8888 | 0.010 |
Why?
|
Insurance, Health | 1 | 2016 | 2518 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2013 | 2682 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2483 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1737 | 0.010 |
Why?
|
Anxiety | 1 | 2015 | 4677 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3709 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9094 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11119 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8512 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 54950 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7885 | 0.010 |
Why?
|
Depression | 1 | 2015 | 8240 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30266 | 0.000 |
Why?
|
Prognosis | 1 | 2004 | 30044 | 0.000 |
Why?
|